ArticleBMC pediatrics2026
Association between maternal MTHFR and MTRR gene polymorphisms and the risk of congenital heart disease in newborns.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlthough numerous studies have explored the maternal genetic contributions to Congenital Heart Disease (CHD), their findings remain inconsistent. This study aimed to investigate the association between maternal gene polymorphisms and neonatal CHD risk in the Chinese Han population from southern Fujian.
methodsWe conducted a hospital-based case–control study between January 2023 and December 2024, involving 155 mothers of neonates with CHD and 160 healthy controls. Polymorphisms in MTHFR (rs1801133 and rs1801131) and MTRR (rs1801394) were genotyped using Sanger sequencing.
resultsOur study showed that maternal polymorphism of MTHFR at rs1801133 was associated with a significantly increased risk of neonata CHD in the crude analysis (OR = 1.665, 95%CI: 1.168–2.371; P = 0.005, FDR_P = 0.018), which remained robust after adjusting for maternal age (OR = 1.646, 95%CI: 1.158–2.340; P = 0.005, FDR_P = 0.018) and further for folic acid use (OR = 1.607, 95%CI: 1.117–2.314; P = 0.011, FDR_P = 0.018) under the additive model. Mothers carried the variant allele (CT + TT) had a significantly higher odds of CHD compared with non-carriers (CC) in the fully adjusted model (OR = 1.725, 95%CI: 1.081–2.754; P = 0.022, FDR_P = 0.044) under the dominant model. MTRR rs1801394 was associated with a significantly increased risk of neonata CHD in the crude analysis (OR = 1.588, 95%CI: 1.114–2.261; P = 0.010, FDR_P = 0.020), which remained robust after adjusting for maternal age (OR = 1.601, 95%CI: 1.118–2.291; P = 0.010, FDR_P = 0.020) and further for folic acid use (OR = 1.544, 95%CI: 1.065–2.237; P = 0.022, FDR_P = 0.044) under the additive model. Mothers with the TT genotype at rs1801133 of the MTHFR gene had significantly higher serum Hcy levels than those with the CC or CT genotypes, and with the GG genotype at rs1801394 of MTRR higher than those with the AA genotype. Hcy partially mediated the associations between maternal genotypes (rs1801133 and rs1801394) and neonatal CHD, with a Prop.Mediated of 24.7% and 23.8% respectively (both P < 0.05).
conclusionMaternal polymorphisms in MTHFR rs1801133 and MTRR rs1801394 were significantly associated with increased risk of neonatal CHD in the Chinese Han population of southern Fujian. Maternal polymorphisms in MTHFR rs1801133 and MTRR rs1801394 were significantly associated with elevated maternal serum Hcy levels, and Hcy partially mediated the associations between maternal genotypes (rs1801133 and rs1801394) and neonatal CHD.
trial registrationThis was an observational study. According to the International Committee of Medical Journal Editors (ICMJE), purely observational studies (in which the allocation of medical interventions is not under the investigator's discretion) do not require registration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.